Abstract:

Olfaction, an ancient sensory system, provides intricate information about the environment. In emulation of this biological process, neuromorphic devices in conjunction with machine learning algorithms, endeavor to replicate and digitize the olfactory capabilities. This presentation focuses on the gas discrimination and identification capabilities of neuromorphic nanosensors. By leveraging machine learning, our electronic olfaction system demonstrates exceptional capabilities applicable to diverse fields such as pathogen detection, environmental monitoring, and disease diagnosis. The fusion of neuromorphic nanosensors and machine learning algorithms creates a powerful synergy, paving the way for advanced molecular sensing technologies with broad-ranging applications.

Biography：
Prof. Gianaurelio Cuniberti has held the Chair of Materials Science and Nanotechnology at Technische Universität Dresden (TU Dresden) since 2007 and is affiliated with the Max Bergmann Center of Biomaterials in Dresden, Germany. He is a member of TU Dresden's School of Engineering Sciences (Materials Science) and the School of Science (Physics). After earning his B.Sc. and M.Sc. in Physics from the University of Genoa, Italy, he obtained his Ph.D. in 1997 at age 27 through a collaboration with the University of Hamburg, Germany. He has been a visiting scientist at MIT and the Max Planck Institute for the Physics of Complex Systems. With over 400 journal publications, his research is internationally recognized. Previously, he led a Volkswagen Foundation Research Group at the University of Regensburg. Prof. Cuniberti is an elected member of the European Academy of Sciences, Academia Europaea, and Germany’s National Academy of Science and Engineering (acatech). In 2024, he was honored as an Officer of the Order of the Star of Italy by the President of the Republic of Italy.

Abstract:

Cancer, the second leading cause of premature mortality worldwide, is expected to become the leading cause in many countries by the end of this century. External beam radiation therapy, a cornerstone of cancer treatment, aims to target tumors precisely while sparing healthy tissues. However, unintended radiation exposure beyond the target area—resulting from leakage or scatter—remains a concern, especially for children and adolescents. Advances in pediatric oncology have improved five-year survival rates to over 80% for many childhood cancers, yet approximately 60% of survivors develop chronic health conditions, with 25% facing life-threatening complications. Proton therapy, particularly effective for encephalic treatments, has emerged as a transformative approach, minimizing cognitive risks and secondary tumor formation, thereby improving long-term outcomes for young patients.

Biography：

Dr. Chiara Valentini has made significant contributions to Radiation Oncology through her leadership, research, and educational roles. She has served as Senior Consultant for Pediatric Radiation Therapy since January 2024, building on her role as Head of Pediatric Radiation Therapy at UKD Dresden since 2022. Notably, she co-led the installation of a Hybrid-MRI Linear Accelerator at UKD Dresden, a pioneering project initiated in 2021. An active Board member of ESTRO’s FALCON Group, she advances international collaboration and education. Dr. Valentini earned her Ph.D. from OncoRay, TU Dresden, focusing on Head and Neck cancer research. As Co-Director of the ESTRO-FALCON Workshop and an ESTRO tutor since 2015, she is dedicated to education. Fluent in German, Italian, and English, she bridges cultural and professional contexts with excellence.